IHH Healthcare Bhd
KLSE:IHH
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
5.8
7.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches MYR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
IHH Healthcare Bhd
Net Income (Common)
IHH Healthcare Bhd
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
I
|
IHH Healthcare Bhd
KLSE:IHH
|
Net Income (Common)
myr2.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
35%
|
CAGR 10-Years
14%
|
|
|
K
|
KPJ Healthcare Bhd
KLSE:KPJ
|
Net Income (Common)
myr312.4m
|
CAGR 3-Years
58%
|
CAGR 5-Years
12%
|
CAGR 10-Years
10%
|
|
|
F
|
Focus Point Holdings Bhd
KLSE:FPHB
|
Net Income (Common)
myr32.7m
|
CAGR 3-Years
33%
|
CAGR 5-Years
27%
|
CAGR 10-Years
23%
|
|
|
C
|
Cengild Medical Bhd
KLSE:CENGILD
|
Net Income (Common)
myr11.1m
|
CAGR 3-Years
3%
|
CAGR 5-Years
50%
|
CAGR 10-Years
N/A
|
|
IHH Healthcare Bhd
Glance View
IHH Healthcare Bhd is a premier healthcare provider in Asia, known for its commitment to delivering quality medical services across multiple countries including Malaysia, Singapore, Turkey, and India. Established in 1990, the company has grown significantly through strategic acquisitions and organic expansion, becoming one of the largest healthcare operators globally. Its diverse portfolio encompasses hospitals, medical centers, and clinics that provide a comprehensive range of healthcare services, from advanced tertiary care to outpatient services. Investors are drawn to IHH for its robust growth potential, strong market position, and its ability to tap into the increasing healthcare demand driven by an aging population and rising middle class across Asia. The company's operational excellence is backed by a diverse revenue stream, primarily generated from inpatient and outpatient services, diagnostic services, and healthcare-related products. IHH Healthcare is not only focused on expansion but also invests heavily in technology and innovative healthcare solutions, which enhances efficiency and patient care. With a proven track record of financial performance, characterized by steady revenue growth and a solid balance sheet, IHH Healthcare presents a compelling investment opportunity. For investors looking for exposure in the resilient and rapidly evolving healthcare sector, IHH stands out as a leader with a vision to elevate global healthcare standards while delivering sustainable returns.
See Also
What is IHH Healthcare Bhd's Net Income (Common)?
Net Income (Common)
2.7B
MYR
Based on the financial report for Jun 30, 2024, IHH Healthcare Bhd's Net Income (Common) amounts to 2.7B MYR.
What is IHH Healthcare Bhd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
14%
Over the last year, the Net Income (Common) growth was 25%. The average annual Net Income (Common) growth rates for IHH Healthcare Bhd have been 21% over the past three years , 35% over the past five years , and 14% over the past ten years .
You don't have any saved screeners yet
